PharmaDrug CEO Provides Vision for Securedose Acquisition

Toronto, Ontario – December 13, 2023 – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of...

Anfield Energy Announces Private Placement

VANCOUVER, British Columbia, Dec. 07, 2023 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it will conduct a non-brokered private placement for up to 40,000,000 Units at a price of $0.065...

Kontrol Technologies Provides Corporate Update

TORONTO – Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), provides a corporate update on its progress towards its 2023 strategic objectives. “We are pleased with our progress and continued execution of our key strategic...

PharmaDrug Inc. Closes Acqusition of Securedose Synthetics

Toronto, Ontario – November 7, 2023 – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company”), is pleased to announce that it has closed the previously announced acquisition (see press release dated October 27,...